Skip to main content
SpringerLink
Log in

New Clinical Syndromes under Regular Intermittent Hemodialysis

  • Conference paper
Glomerulonephritis

Part of the book series: Current Topics in Pathology ((CT PATHOLOGY,volume 61))

Abstract

Until about 1960, patients with progressive renal failure inevitably died from uremia. Therapy was symptomatic only and prolongation of life to any significant degree was not possible. Within the past 15 years many thousands of patients have survived end-stage renal failure by intermittent hemodialysis treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

Sections 1–5

  1. Ahearn, D. J., Maher, J. F.: Heart failure as a complication of hemodialysis. Arteriovenous Fistula. Ann. Int. Med. 77, 201–204 (1972)

    PubMed  CAS  Google Scholar 

  2. Alfrey, A. C., Lueker, R., Goss, J. E., Vogel, J. H. K., Faris, T. D., Holmes, J. H.: Control of arteriovenous shunt flow. J. Amer. Med. Ass. 214, 884–888 (1970)

    CAS  Google Scholar 

  3. Asbury, A. K., Victor, M., Adams, R. D.: Uremic polyneuropathy. Arch. Neurol. (Chicago) 8, 413 (1963)

    CAS  Google Scholar 

  4. Bagdade, J. D.: Disorders of carbohydrate and lipid metabolism in uremia. Nephron 14, 153–162 (1975)

    PubMed  CAS  Google Scholar 

  5. Bagdade, J. D., Porte, D., Biermann, E.: Hypertriglyceridemia. — A consequence of chronic renal failure. New Engl. J. Med. 279, 181–185 (1968)

    PubMed  CAS  Google Scholar 

  6. Bagdade, J. D.: Uremic lipemia: Abnormal triglycerid transport in chronic renal failure. In: Uremia. Stuttgart: Georg Thieme. 1972

    Google Scholar 

  7. Bailey, G. L., Hampers, C. L., Merrill, J. R.: Reversible cardiomyopathy in uremia. Vol. XIII Trans. Amer. Soc. Artif. Int. Organs (1967)

    Google Scholar 

  8. Brass, H., Krückels, E. D., Müller, G., Heintz, R.: Pathomechanismen der Herzinsuffizienz bei Hämodialysepatienten. Dtsch. Med. Wschr. 96, 1319–1324 (1971)

    PubMed  CAS  Google Scholar 

  9. Bundschu, H. G., Lüders, G., Dürr, F.: Morphologische Veränderungen an Gonaden hämodialysierter chronisch nierenkranker Männer. Symp. Ges. Nephrol. Aachen: Heintz and Holzhüter, 1971, VIII

    Google Scholar 

  10. Cohen, A. D., Gower, P. E., Rogers, K. Ll., Pegrum, G. D., de Wardener, H. E.: Reproductive potential in males treated by chronic haemodialysis. Proceedings of the 10th Congress of the EDTA, Vol. 10 (1973)

    Google Scholar 

  11. Coleman, T. G., Bower, J. D., Langford, H. G., Guyton, A. C.: Regulation of arterial pressure in the anephric state. Circulation, Vol. XLII, 509–514 (1970)

    Google Scholar 

  12. Craswell, P. W., Hird, V. M., Judd, P. A., Baillod, R. A., Varghese, Z., Moorhead, J. F.: Plasma renin activity and blood pressure in 89 patients receiving maintenance haemodialysis therapy. Brit. Med. J. 4, 749–753 (1972)

    PubMed  CAS  Google Scholar 

  13. Craswell, P. W., Hird, V. M., Baillod, R. A., Varghese, Z., Moorhead, J. F.: Significance of high plasma renin activity in patients on maintenance haemodialysis therapy. Brit. Med. J. 2, 741–743 (1973)

    PubMed  CAS  Google Scholar 

  14. Dobbelstein, H.: Die urämische Neuropathie in Abhängigkeit von Dialysedauer und-gerät. Klin. Wschr. 50, 533–535 (1972)

    PubMed  CAS  Google Scholar 

  15. Floyd, M. D., Agyar, D. R, Hudgson, P., Kerr, D. N. S.: Myopathy in chronic renal failure. Proc. Europ. Dial. Transpl. Ass. 6 (1969)

    Google Scholar 

  16. Fraley, E. E., Feldman, B. H.: Renal hypertension. New Engl. J. Med. 287, 550–552 (1972)

    PubMed  CAS  Google Scholar 

  17. Gurland, H. J., Brunner, F. P., V. Dehn, H., Härlen, H., Parsons, F. M., Schärer, K.: Combined report on regular dialysis and transplantation in Europe, III, 1972. In: Proceedings of the European Dialysis and Transplant Association, 10, London: Pitman Medical, 1973

    Google Scholar 

  18. Hampers, C. L., Lowrie, E. G., Soeldner, J. S., Merrill, J. P.: Uremia and carbohydrate metabolism. In: Uremia. Stuttgart: Georg Thieme, 1972

    Google Scholar 

  19. Heron, J. R., Konotey-Ahulu, F. I., Shaldon, S., Thomas, P. K.: Nerve conduction in chronic renal failure treated by dialysis. Proc. Europ. Dial. Transpl. Ass. 2 (1965)

    Google Scholar 

  20. Hübner, W., Diemer, A., Frieberg, J.: Das Verhalten der urämischen Hyperlipidämie und Glukosetoleranzstörung unter chronisch intermittierender Hämodialysebehandlung. Med. Welt 23, 1415–1417 (1972)

    PubMed  Google Scholar 

  21. Jennekens, F. G. I., van der Most, D., van Spijk, E. J., Dorhout Mess: Nerve fiber degeneration in uremic polyneuropathy. Proc. Europ. Dial. Transpl. Ass. 6 (1969)

    Google Scholar 

  22. Kennedy, A. C., Linton, A. L., Luke, R. G., Renfrew, S., Dinwoodie, A.: The pathogenesis and prevention of cerebral dysfunction during dialysis. Lancet 792 (1964)

    Google Scholar 

  23. Konothey-Ahulu, F. I. D., Baillod, R., Comty, C. M., Heron, J. R., Shaldon, S., Thomas, P. K.: Effects of periodic dialysis on the peripheral neuropathy of end-stage renal failure. Brit. Med. J. 2, 1212 (1965)

    Google Scholar 

  24. Klütsch, K., Kult, J., Grosswendt, J.: Die Hämodynamik regelmäßig hämodialysierter Patienten. Wissenschaftliche Information Fresenius, Aktuelle Nephrologie 1, 47–63 (1972)

    Google Scholar 

  25. Lindner, A., Charra, B., Sherrard, D. J., Schribner, B. H.: Accelerated atherosclerosis in prolonged maintenance hemodialysis. New Engl. J. Med. 290, 697–701 (1974)

    PubMed  CAS  Google Scholar 

  26. Lüderitz, B., Bolte, H. D.: Chronische Niereninsuffizienz und muskelzelluläre Erregbarkeit. In: Aktuelle Probleme der Dialyseverfahren und der Niereninsuffizienz. Friedberg: Bindernagel, 1971

    Google Scholar 

  27. Perkhoff, G. T., Thomas, C. L., Newton, J. C., Sellmann, J. C., Tyler, F. H.: Mechanisms of impaired glucose tolerance in uremia and experimental hyperazotemia. Diabetes 7, 375 (1958)

    Google Scholar 

  28. Piehl, W., Wilbrandt, R., Freyland, M. D., Frotscher, U., Messerschmidt, W.: Herzbeuteltamponade bei terminaler Niereninsuffizienz. Dtsch. med. Wschr. 96, 1249–1251 (1971)

    PubMed  CAS  Google Scholar 

  29. Pippig, L.: Herz-und Kreislauffunktion bei Urämie. Arch. Klin. Med. 214, 244–272 (1968)

    PubMed  CAS  Google Scholar 

  30. Schreiner, G. E., Mahler, J. F.: Hemodialysis for chronic renal failure. Medical, moral and ethical, and socio-economic problems. Ann. Int. Med. 62, 551 (1965)

    PubMed  CAS  Google Scholar 

  31. Schulz, W., Gessler, U.: Renale Hypertonie und bilaterale Nephrektomie. Nierenund Hochdruckkrankheiten 6, 258–261 (1973)

    Google Scholar 

  32. Siddiqui, J., Kerr, D. N. S.: Complications of renal failure and their response to dialysis. Brit. Med. Bull. 27/2, 153–159 (1971)

    Google Scholar 

  33. Sill, V., Lanser, K. G., Bauditz, W.: Einfluß der Anämie und der arteriovenösen Fistel auf die körperliche Leistungsfähigkeit der Dauerdialysepatienten. Z. Kardiologie 62, 164–175 (1972)

    Google Scholar 

  34. Sill, V., Tilsner, V., Bauditz, W.: Beeinflussung der Hämodynamik durch arteriovenöse Fisteln bei Dialyse-Patienten. Dtsch. Med. Wschr. 94, 1604–1607 (1969)

    PubMed  CAS  Google Scholar 

  35. Smith, H.: In: Research in muscular dystrophy. London: Ditman Medical, 1968

    Google Scholar 

  36. Tenckhoff, H. A., Boen, F. S. T., Jebsen, R. H., Spiegler, J. H.: Polyneuropathy in chronic renal insufficiency. J. Amer. Med. Ass. 192, 1121 (1965)

    CAS  Google Scholar 

  37. Vertes, V., Cangiano, J. L., Berman, L. B., Gould, A.: Hypertension in endstage renal failure. New Engl. J. Med. 280, 978 (1969)

    PubMed  CAS  Google Scholar 

  38. Wagner, H., Böckel, K., Hrubesch, M., Schulz, H., Loew, H.: Hypogonadismus bei männlichen Dauerdialysepatienten. Aktuelle Probleme der Dialyseverfahren und der Niereninsuffizienz. In: Fifth Symposium, Innsbruck, Feb 1974. In press

    Google Scholar 

  39. Wiegand, M. E., Meents, O., Heidland, A.: Cochleovestibuläre Störungen bei Patienten mit terminaler Niereninsuffizienz. In: Aktuelle Probleme der Dialyseverfahren und Niereninsuffizienz. Friedberg: Bindernagel, 1971

    Google Scholar 

  40. Zumkley, H., Losse, H., Westerboer, S.: Hypernatriämie als Ursache urämischer Encephalopathien. VI. Symposium Ges. Nephrologie, Wien, 1968

    Google Scholar 

  41. Zumkley, H.: Differentialdiagnose renaler Encephalopathien. Med. Welt 23, 555–559 (1972)

    PubMed  CAS  Google Scholar 

Section 6

  1. Albright, F., Burnett, L. H., Parson, W., Reifenstein, E. C., Roos, A.: Osteomalacia and late rickets. Various etiology met in the United States with emphasis on that resulting from specific form of renal acidosis, therapeutic indications for each etiological subgroup, and relationship between osteomalacia and Milkman’s syndrome. Medicine (Baltimore) 25, 1946, 399–406

    CAS  Google Scholar 

  2. Avioli, L. V.: The therapeutic approach to hypoparathyroidism. Amer. J. Med. 57, 1974, 34–42

    PubMed  CAS  Google Scholar 

  3. Avioli, L. V., Birge, S. J., Slatopolsky, E.: The Nature of Vitamin D Resistance of Patients with Chronic Renal Disease. Arch. Intern. Med. 124, 1969, 451–454

    PubMed  CAS  Google Scholar 

  4. Avioli, L. V., Birge, S. J., Won Lee, S., Slatopolsky, E.: The metabolic fate of vitamin D3-3H in chronic renal failure. J. Clin. Invest. 47, 1968, 2239–2252

    PubMed  CAS  Google Scholar 

  5. Avioli, L. V., Haddad, J. G.: Vitamin D: Current Concepts. Metabolism 22, 1973, 507–531

    PubMed  CAS  Google Scholar 

  6. Avioli, L. V., Won Lee, S., McDonald, J. E., Lund, J., Deluca, H. F.: Metabolism of Vitamin D3-3H in Human Subjects: Distribution in Blood, Bile, Feces, and Urine. J. Clin. Invest. 46, 1967, 983–992

    PubMed  CAS  Google Scholar 

  7. Ball, J., Garner, A.: Mineralisation of woven bone in osteomalacia. J. Path. Bact. 91, 1966, 563–574

    PubMed  CAS  Google Scholar 

  8. Belsey, R. E., DeLuca, H. F., Potts, J. T.: A Rapid Assay for 25-OH-Vitamin D3 Without Preparative Chromatography. J. Clin. Endocrin. Met. 38, 1974, 1046–1061

    CAS  Google Scholar 

  9. Berlyne, G. M.: Microcrystalline Conjunctival Calcification in Renal Failure. Lancet I 1968, 366–370

    Google Scholar 

  10. Berlyne, G. M.: Red Eyes in Renal Failure. Lancet I 1967, 4–7

    Google Scholar 

  11. Berson, S. A., Yalow, R. S.: Parathyroid hormone in plasma in adenomatous hyperparathyroidism, uremia and bronchogenic carcinoma. Sci. 154, 1966, 90–7912

    Google Scholar 

  12. Binswanger, U., Fischer, J., Schenk, R., Merz, W.: Osteopathie bei chronischer Niereninsuffizienz. Dtsch. med. Wschr. 96, 1971, 1914–1919

    PubMed  CAS  Google Scholar 

  13. Blunt, J. W., DeLuca, H. F., Schnoes, H. K.: 25-Hydroxycholecalciferol. A Biologically Active Metabolite of Vitamin D3. Biochemistry 7, 1968, 3317–3322

    PubMed  CAS  Google Scholar 

  14. Boyle, I. T., Gray, R. W. DeLuca, H. F.: Regulation by Calcium of in vitro Synthesis of 1,25-Dihydroxycholecalciferol and 21,25-Dihydroxycholecalciferol. Proc. Nat. Acad. Sci. USA 68, 1971, 2131–2134

    PubMed  CAS  Google Scholar 

  15. Boyle, I. T., Gray, R. W., Omdahl, J. L., DeLuca, H. F.: The mechanism of adaption of intestinal calcium absorption to low dietary calcium. J. Lab. Clin. Med. 78, 1971, 813

    PubMed  CAS  Google Scholar 

  16. Bricker, N. S., Slatopolsky, E., Reiss, E., Avioli, L. V.: Calcium, Phosphorus, and Bone in Renal Disease and Transplantation. Arch. Intern. Med. 123, 1969, 543–553

    PubMed  CAS  Google Scholar 

  17. Caner, J. E. Z., Decker, J. L.: Recurrent Acute (? Gouty) Arthritis in Chronic Renal Failure Treated with Periodic Hemodialysis. Amer. J. Med. 36, 1964, 571–582

    PubMed  CAS  Google Scholar 

  18. Chase, L. R., Slatopolsky, E.: Secretion and Metabolie Efficacy of Parathyroid Hormone in Patients with Severe Hypomagnesemia. J. Cli. Endocr. Metab. 38, 1974, 363–371

    CAS  Google Scholar 

  19. Clarkson, E. M., Luck, V. A., Hynson, W. V., Bailey, R. R., Eastwood, J. B., Woodhead, J. S., Clements, V. R., O’Riordan, J. L. H., de Wardener, H. E.: The effect of Aluminium Hydroxyde on Calcium, Phosphorus and Aluminium Balances, the Serum Parathyroid Hormone Concentration and the Aluminium Content of Bone in Patients with Chronic Renal Failure. Clin. Sci. 43, 1972, 519–531

    PubMed  CAS  Google Scholar 

  20. Clarkson, E. M., McDonald, S. J., de Wardener, H. E.: The Effect of a High Intake of Calcium Carbonate in Normal Subjects and Patients with Chronic Renal Failure. Clin. Sci. 30, 1966, 425–438

    PubMed  CAS  Google Scholar 

  21. Cochran, M., Nordin, B. E. C.: Role of Acidosis in Renal Osteomalacia. Brit. Med. J. 2, 1969, 276–279

    PubMed  CAS  Google Scholar 

  22. Corradino, R. A., Wasserman, R. H.: Vitamin D3: Induction of Calcium-Binding Protein in Embryonie Chick Intestine in vitro. Sci. 172, 1971, 731–733

    CAS  Google Scholar 

  23. Cousins, R. J., DeLuca, H. F., Gray, R. W.: Metabolism of 25-Hydroxycholecalciferol in Target and Nontarget Tissues. Bioch. 9, 1970, 3649–3654

    CAS  Google Scholar 

  24. Cousins, R. J.: Deluca, H. F., Suda, T., Chen, T., Tanaka, Y.: Metabolism and Subcellular Location of 25-Hydroxycholecalciferol in Intestinal Mucosa. Biochemistry 9, 1079, 1453–1458

    Google Scholar 

  25. Crawford, T., Dent, C. E., Lucas, P., Martin, N. H.: Osteosc1erosis Associated with Chronic Renal Failure. Lancet 11, 1954, 981–989

    Google Scholar 

  26. Dambacher, M. A., Girad, J., Haas, H. G.: Die Vitamin D-Hormone. Neue Erkenntnisse über Stoffwechsel und Therapie. Der Internist 13, 1972, 125–132

    PubMed  CAS  Google Scholar 

  27. Delling, G.: Quantitative Auswertung von Skeletveränderungen bei chronischer Hämodialyse. Verh. Dtsch. Ges. f. Path. 56. Tagung. 1972, 436–438

    CAS  Google Scholar 

  28. DeLuca, H. F.: The Role of Vitamin D and Its Relationship to Parathyroid Hormone and Calcitonin. Rec. Prog. Horm. Res. 27, 1971, 479–516

    PubMed  CAS  Google Scholar 

  29. DeLuca, H. F.: Parathyroid Hormone as a Trophic Hormone for 1,25-Dihydroxy-vitamin D3, the Metabolically Active Form of Vitamin D. New Engl. J. Med. 287, 1972, 250–251

    PubMed  CAS  Google Scholar 

  30. DeLuca, H. F.: 25-Hydroxycholecalciferol. The Probable Metabolically Active Form of Vitamin D3: Its Identification and Subcellular Site of Action. Arch. Intern. Med. 124, 1969, 442–450

    PubMed  CAS  Google Scholar 

  31. DeLuca, H. F.: Neue Erkenntnisse über den Vitamin D-Stoffwechsel. Triangel 12, 1974, 111–118

    Google Scholar 

  32. DeLuca, H. F., Avioli, L. V.: Treatment of Renal Osteodystrophy with 25-Hydroxycholecalciferol. Arch. Intern. Med. 126, 1970, 896–899

    PubMed  CAS  Google Scholar 

  33. Drescher, D., DeLuca, H. F.: Possible Precursor of Vitamin D Stimulated Calcium Binding Protein in Rats. Biochemistry 10, 1971, 2308–2312

    PubMed  CAS  Google Scholar 

  34. Drukker, W., Haagsma-Schouten, W. A. G., Alberts, G., Baarda, B.: Zit. nach: Ritz, E., Sieberth, H. G., und Krempien, B.: Ca-Stoffwechselstörungen bei chronischer Niereninsuffizienz. Klin. Wschr. 49, 1971, 1305–1314

    Google Scholar 

  35. Duursma, S. A., Visser, W. J., Njio, L.: A quantitativ histological study of bone in 30 Patients with renal insufficiency. Calc. Tiss. Res. 9, 1972, 216–221

    CAS  Google Scholar 

  36. Faser, D. R., Kodicek, E.: Unique Biosynthesis by Kidney of a Biologically Active Vitamin D Metabolite. Nature 228, 1970, 764–766

    Google Scholar 

  37. Fournier, A. E., Arnaud, C. D., Johnson, W. J., Taylor, W. F., Goldsmith, R. S.: Etiology of Hyperparathyroidism and Bone Disease during Chronic Hemodialysis. II. Factors Affecting Serum Immunoreactive Parathyroid Hormone. J. Clin. Invest. 50, 1971, 599–605

    PubMed  CAS  Google Scholar 

  38. Friis, Th., Hahnemann, S., Weeke, E.: Serum Calcium and Serum Phosphorus in Uremia during Administration of Serum Phytate and Aluminium Hydroxide. Acta Med. Scand. 183, 1968, 497–502

    PubMed  CAS  Google Scholar 

  39. Friis, Th., Weeke, E.: Effect of Aluminium Hydroxyde upon Serum Calcium, Serum Phosphorus and Calcium Turnover in Uremic Patients. Acta Med. Scand. 187, 1970, 41–46

    PubMed  CAS  Google Scholar 

  40. Frolik, C. A., DeLuca, H. F.: 1,25-Dihydroxycholecalciferol: The Metabolite of Vitamin D Responsible for Increased Calcium Transport. Arch. Biochemistry and Bioph. 147, 1971, 143–147

    CAS  Google Scholar 

  41. Frolik, C. A., DeLuca, H. F.: Metabolism of 26,27-3H-1,25-Dihydroxycholecalciferol. Fed. Proc. 31, 1, 1972, 693

    Google Scholar 

  42. Garabedian, M., Holick, M. F., Deluca, H. F., Boyle, I. T.: Control of 25-Hydroxycholecalciferol Metabolism by Parathyroid Glands. Proc. Nat. Acad. Sci. USA. 689, 1972, 1673–1676

    Google Scholar 

  43. Garner, A., Ball, J.: Quantitative Observation on Mineralised and Unmineralised Bone in Chronic Renal Azotemie and Intestinal Malabsorption Syndrome. J. Path. Bact. 91, 1966, 545–549

    PubMed  CAS  Google Scholar 

  44. Gral, Th.: Medizinische Probleme der chronischen Hämodialyse. Med. Welt 10, 1968, 637–642

    PubMed  CAS  Google Scholar 

  45. Gray, R. W., Boyle, I., DeLuca, H. F.: Vitamin D Metabolism: The Role of Kidney Tissue. Sci. 172, 1971, 1232–1234

    CAS  Google Scholar 

  46. Gray, R. W., Omdahl, J. L., Ghazarian, H. G., DeLuca, H. F.: 25(OH)-Vitamin D3-Hydroxilation. Fed. Proc. 31, 1972, 693

    Google Scholar 

  47. Hallick, R. B., DeLuca, H. F.: Metabolites of Dihydrotachysterol in Target Tissues. J. Biol. Chem. 247, 1972, 91–97

    PubMed  CAS  Google Scholar 

  48. Harrison, H. C., Harrison, H. E.: Comparison of Activity of 25-Hydroxycholecalciferol and Dihydrotachysterol in the Thyroparathyroidectomized Rat. Proc. Soc. Exper. Biol. Med. 136, 1971, 411–414

    CAS  Google Scholar 

  49. Harrison, H. E., Harrison, H. C.: Dihydrotachysterol: a Calcium Active Steroid not Dependent upon Kidney Metabolism. J. Clin. Invest. 51, 1972, 1919–1922

    PubMed  CAS  Google Scholar 

  50. Harrison, H. E., Harrison, H. C.: Difference between Cholecalciferol and Dihydrotachysterol with Respect to Activation by Kidney. Fed. Proc. 31, 1972, 226

    Google Scholar 

  51. Hartenbower, D. L., Coburn, J. W., Reddy, C. R., Norman, A. W.: Possible Role of Impaired Renal Production of 1,25-DiOH-Cholecaleiferol in Causing Reduced Calcium Absorption in Chronic Uremia. Clin. Res. 20, 1972, 595

    Google Scholar 

  52. Haussler, M. R.: Studies on the Production of 25-Hydroxy-Vitamin D3 and 1,25-Dihydroxy-Vitamin D3 in vitro. Fed. Proc. 31, 1972, 694

    Google Scholar 

  53. Haussler, M. R., Boyce, D. W., Littledike, E. T., Rasmussen, H.: A Rapidly Acting Metabolite of Vitamin D3. Proc. Nat. Acad. Sci. USA. 68, 1971, 177–181

    PubMed  CAS  Google Scholar 

  54. Heidbreder, E., Hennemann, H., Heidland, A.: Renale Osteodystrophie. Med. Welt 25, 1974, 736–744

    PubMed  CAS  Google Scholar 

  55. Heintz, R., Renner, D.: über Hemmwirkungen des Serums von Kranken mit hepatorenalem Syndrom und mit chronischer Urämie auf Sauerstoffverbrauch und Kohlenhydratstoffwechsel von Nieren und Hirngewebe der Ratte. Klin. Wschr. 43, 1965, 1167–1173

    PubMed  CAS  Google Scholar 

  56. Henning, H. V., Quellhorst, E., Scheler, F.: Myocardverkalkung als letale Komplikation bei chronischer Niereninsuffizienz. Med. Klin. 64, 1969, 1591–1595

    PubMed  CAS  Google Scholar 

  57. Herrath, D. von, Kraft, D., Grigoleit, H.-G., Schaefer, K.: Die Behandlung der urämischen Osteopathie. II. Die Wirkung von 5,6-trans-25-Hydroxycholecalciferol bei terminaler Niereninsuffizient. Dtsch. med. Wschr. 98, 1973, 1379–1381

    Google Scholar 

  58. Herrath, D. von, Schaefer, K., Koch, H. U., Opitz, A., Stratz, R.: Vitamin D-Stoffwechsel bei experimenteller Urämie. Zschr. ges. exp. Med. 155, 1971, 315–324

    Google Scholar 

  59. Hesch, R.-D., Gerlach, W., Henning, H. V., Emrich, D., Scheler, F., Kattermann, R.: Untersuchungen zur intestinalen 47Ca-Absorption bei Gesunden und Patienten mit chronischer Niereninsuffizienz. Dtsch. med. Wschr. 97, 1972, 1735–1742

    PubMed  CAS  Google Scholar 

  60. Hesch, R.-D., Henning, H. V., Gerlach, W., Scheler, F.: Früherkennung von Störungen der intestinalen Ca-Absorption bei Niereninsuffizienz. Klin. Wschr. 49, 1971, 115–118

    PubMed  CAS  Google Scholar 

  61. Hill, L. F., van den Berg, C. J., Mawer, E. B.: Zit. nach Heidbreder, E., Hennemann, H., Heidland, A.: Renale Osteodystrophie. Med. Welt 25, 1974, 736–744

    Google Scholar 

  62. Hitt, O., Jaworski, Z. F., Shimizu, A. G., Frost, H. M.: Tissue-level Bone Formation rates in Chronic Renal Failure, Measured by Means of Tetracycline Bone Labeling. Canad. J. Phys. Pharm. 48, 1970, 824–828

    CAS  Google Scholar 

  63. Holick, M. F., DeLuca, H. F., Avioli, L. V.: Isolation and Identification of 25-Hydroxycholecalciferol From Human Plasma. Arch. Intern. Med. 129, 1972, 56–61

    PubMed  CAS  Google Scholar 

  64. Holick, M. F., Garabedian, M., DeLuca, H. F.: 1,25-Dihydroxycholecalciferol: Metabolite of Vitamin D3 Active on Bone in Anephric Rats. Sci. 176, 1972, 1146–1147

    CAS  Google Scholar 

  65. Holick, M. F., Schnoes, H. K., DeLuca, H. F.: Identification of 1,25-Dihydroxycholecalciferol, a Form of Vitamin D3 Metabolically Active in the Intestine. Proc. Nat. Acad. Sci. USA 68, 1971, 803–804

    PubMed  CAS  Google Scholar 

  66. Ingham, J. P., Stewart, J. H., Posen, S.: Quantitative Skeletal Histology in Untreated End-stage Renal Failure. Brit. Med. J. 2, 1973, 745–748

    PubMed  CAS  Google Scholar 

  67. Jowsey, J.: Die mikroradiographische Beurteilung der Knochenstruktur. Triangel 12, 1974, 93–102

    Google Scholar 

  68. Jowsey, J., Massry, S. G., Coburn, J. W., Kleeman, Ch. R.: Microradiographic Studies of Bone in Renal Osteodystrophy. Arch. Intern. Med. 124, 1969, 539–543

    PubMed  CAS  Google Scholar 

  69. Kaye, M., Chatterjee, G., Cohen, G. F., Sagar, S.: Arrest of Hyperparathyroid Bone Disease with Dihydrotachysterol in Patients Undergoing Chronic Hemodialysis. Ann. Intern. Med. 73, 1970, 225–233

    PubMed  CAS  Google Scholar 

  70. Kaye, M., Sagar, S.: Effect of Dihydrotachysterol on Calcium Absorption in Uremia. Metabolism. 51, 1972, 815–824

    Google Scholar 

  71. Kaye, M., Sagar, S.: Dihydrotachysterolin Uremia. Clin. Res. 19, 1971, 809

    Google Scholar 

  72. Kimberg, V. D., Baerg, R. D., Gershon, E.: The Nature of Vitamin D Resistance in Experimental Uremia. Arch. Intern. Med. 126, 1970, 891–895

    PubMed  CAS  Google Scholar 

  73. Kodicek, E., Lawson, D. E. M., Wilson, P. W.: Biological Activity of a Polar Metabolite of Vitamin D3. Nature 228, 1970, 763–764

    PubMed  CAS  Google Scholar 

  74. Kort, R.: Heparin-induzierte Mobilisation von Calcium und anorganischem Phosphat im Zusammenhang mit extraossären Verkalkungen bei chronischer Hämodialyse. Klin. Wschr. 49, 1971, 684–692

    Google Scholar 

  75. Krawitt, E. L., Kunin, A. S.: Intestinal Calcium-Binding Protein and Rickets. Proc. Soc. Exp. Biol. Med. 136, 1971, 530–533

    PubMed  CAS  Google Scholar 

  76. Krempien, B., Ritz, E., Heuck, F.: Osteopathie bei Langzeithämodialyse. Histomorphometrische und microradiographische Untersuchungen. Verh. Dtsch. Ges. Path. 56. Tagung 1972, 439–442

    CAS  Google Scholar 

  77. Kuhlencordt, F., Bauditz, W., Lozano-Tonkin, C., Kruse, H.-P., Augustin, H. J., Rehpenning, W., Bartelheimer, H.: Osteopathien und Calcium-Phosphatstoffwechsel bei chronischer Hämodialyse. Klin. Wschr. 49, 1971, 134–144

    PubMed  CAS  Google Scholar 

  78. Kuhlencordt, F., Kruse, H.-P.: Was ist gesichert in der Therapie der Osteoporose und Osteomalacie? Internist 15, 1974, 588–593

    PubMed  CAS  Google Scholar 

  79. Lange, H., Gossmann, H. H.: Metastatische Verkalkungen während Peritonealdialyse im Terminalstadium einer chronischen Glomerulonephritis. Dtsch. med. Wschr. 92, 1967, 296–300

    PubMed  CAS  Google Scholar 

  80. Laubenthal, F., Reichenberger, M., Reinwein, D.: Vitamin-D-Intoxikation mit tödlichem Ausgang. Dtsch. med. Wschr. 100, 1975, 412–415

    PubMed  CAS  Google Scholar 

  81. Lawson, D. E. M., Faser, D. R., Kodicek, E., Morris, H. R., Williams, D. H.: Identification of 1,25-Dihydroxycholecalciferol, a New Kidney Hormone controlling Calcium Metabolism. Nature 230, 1971, 228–230

    PubMed  CAS  Google Scholar 

  82. Lefke, M., Sieberth, H. G., Firedmann, G.: Röntgenologische Veränderungen bei Calciumstoffwechselstörungen im Terminalstadium der Niereninsuffizienz. Dtsch. med. Wschr. 96, 1971, 283–289

    Google Scholar 

  83. Litzow, J. R., Lemann, J., Jennon, E. J.: The Effect of Treatment of Acidosis on Calcium Balance in Patients with Chronic Azotemic Renal Disease. J. Clin. Invest. 46, 1967, 280–286

    PubMed  CAS  Google Scholar 

  84. Liu, S. H., Chu, H. I.: Studies of Calcium and Phosphorus Metabolism with Special Reference to Pathogenesis and Effects of Dihydrotachysterol. Medicine (Baitimore) 22, 1943, 103–107

    CAS  Google Scholar 

  85. Lumb, G. A., Mawer, E. B., Stanbury, S. W.: The Apparent Vitamin D Resistance of Chronic Renal Failure. A Study of Physiology of Vitamin D in Man. Amer. J. Med. 50, 1971, 421–441

    CAS  Google Scholar 

  86. Mallick, N. P., Berlyne, G. M.: Arterial Calcification after Vitamin-D Therapy in Hyperphosphataemic Renal Failure. Lancet 1968 II, 1316–1320

    Google Scholar 

  87. Martin, D. L., Melancon, M. J., DeLuca, H. F.: Vitamin D Stimulated, Calcium-Depandent Adenosine Triphosphatase from Brush Borders of Rat Small Intestine. Bioch. Biophy. Res. Comm. 35, 1969, 819–823

    CAS  Google Scholar 

  88. Mawer, E. B., Backhouse, J., Holman, C. A., Lumb, G. A., Stanbury, S. W.: The Distribution and Storage of Vitamin D and Its Metabolites in Human Tissues. Clin. Sci. 43, 1972, 413–431

    PubMed  CAS  Google Scholar 

  89. Mawer, E. B., Backhouse, J., Taylor, C. M., Lumb, G. A.: Failure of Formation of 1,25-Dihydroxycholecalciferol in Chronic Renal Insufficiency. Lancet I 1973, 626–631

    Google Scholar 

  90. Norman, A. W., Midgett, R. J., Myrtle, J. F., Nowicki, H. G.: Studies on Calciferol Metabolism. I. Production of Vitamin D Metabolit 4B from 25-OH-Cholecalciferol by Kidney Homogenates. Bioch. Biophy. Res. Comm. 42, 1971, 1082–1087

    CAS  Google Scholar 

  91. Norman, A. W., Myrtle, J. F., Midgett, R. J., Nowicki, H. G.: 1,25-Dihydroxycholecalciferol: Identification of the Proposed Active Form of Vitamin D3 in the Intestine. Sci. 173, 1971, 51–54

    CAS  Google Scholar 

  92. Omdahl, J. L., Boyle, I. T., DeLuca, H. F.: Regulation of 25-Hydroxycholecalciferol Metabolism. Fed. Proc. 31, 1972, 693–695

    Google Scholar 

  93. Omdahl, J. L., Holick, M., Suda, T., Tanaka, Y., DeLuca, H. F.: Biological Activity of 1,25-Dihydroxycholecalciferol. Biochemistry 10, 1971, 2935–2940

    PubMed  CAS  Google Scholar 

  94. Pak, Ch. Y. C., Deluca, H. F., Chavez de Los Rios, J. M., Suda, T., Ruskin, B., Delea, C. S.: Treatment of Vitamin D-Resistant Hypoparathyroidism with 25-Hydroxycholecalciferol. Arch. Intern. Med. 126, 1970, 239–247

    PubMed  CAS  Google Scholar 

  95. Parfitt, A. M.: Soft-Tissue Calcification in Uremia. Arch. Intern. Med. 124, 1969, 544–556

    PubMed  CAS  Google Scholar 

  96. Parfitt, A. M.: Relation Between Parathyroid Cell Mass and Plasma Calcium Concentration in Normal and Uremic Subjects. Arch. Intern. Med. 124, 1969, 269–273

    PubMed  CAS  Google Scholar 

  97. Piazolo, P., Schleyer, M., Franz, H. E.: Das calciumbindende Protein in der menschlichen Darmschleimhaut bei Urämie. Klin. Wschr. 50, 603–605 (1972)

    PubMed  CAS  Google Scholar 

  98. Ponchon, G., DeLuca, H. F.: The Role of the Liver in the Metabolism of Vitamin D. J. Clin. Invest. 48, 1969, 1273–1279

    PubMed  CAS  Google Scholar 

  99. Ponchon, G., Kennan, A. L., DeLuca, H. F.: Activation ofVitamin D by the Liver. J. Clin. Invest. 48, 1969, 2032–2037

    PubMed  CAS  Google Scholar 

  100. Potts, J. T., Reitz, R. E., Deftos, L. J., Kaye, M., Richardson, J. A., Buckle, R. M., Aurbach, G. D.: Secondary Hyperparathyroidism in Chronic Renal Disease. Arch. Intern. Med. 124, 1969, 408–412

    PubMed  CAS  Google Scholar 

  101. Puschett, J. B., Moranz, J., Kurnick, W. S.: Evidence for a Direct Action of Cholecalciferol and 25-Hydroxycholecalciferol on the Renal Transport of Phosphate, Sodium, and Calcium. J. Clin. Invest. 51, 1972, 373–385

    PubMed  CAS  Google Scholar 

  102. Quellhorst, E., Willms, B., Scheler, F.: Erfahrungen mit der intermittierenden Dialysebehandlung chronisch Nierenkranker. Verh. Dtsch. Ges. inn. Med. 72, 1966, 407–411

    Google Scholar 

  103. Raisz, L. G.: Physiologic and Pharmacologic Regulation of Bone Resorption. New Engl. J. Med. 282, 1970, 909–913

    PubMed  CAS  Google Scholar 

  104. Raisz, L. G., Trummel, C. L., Holick, M. F., DeLuca, H. F.: 1,25-Dihydroxycholecalciferol. Sci. 175, 1972, 768–769

    CAS  Google Scholar 

  105. Rasmussen, H., Deluca, H. F., Arnaud, C., Hawker, Ch., von Stedingh, M.: The Relationship Between Vitamin D and Parathyroid Hormone. J. Clin. Invest. 42, 1963, 1940–1946

    PubMed  CAS  Google Scholar 

  106. Rasmussen, H., Wong, M., Bikle, D., Goddman, D. B. P.: Hormonal Control of the Renal Conversion of 25-Hydroxycholecalciferol to 1,25-Dihydroxycholecalciferol. J. Clin. Invest. 51, 1972, 2502–2504

    PubMed  CAS  Google Scholar 

  107. Reiss, E., Canterbury, J. M., Kanter, A.: Circulating Parathyroid Hormone Concentration in Chronic Renal Insufficiency. Arch. Intern. Med. 124, 1969, 417–422

    PubMed  CAS  Google Scholar 

  108. Ritz, E.: Experimentelle Untersuchungen zum intestinalen Calciumtransport bei Urämie. Zschr. ges. exp. Med. 152, 1970, 313–324

    CAS  Google Scholar 

  109. Ritz, E., Andassy, K., Krempien, B.: Osteopathie bei Dauerdialyse. Med. Klin. 67, 1972, 1132–1127

    PubMed  CAS  Google Scholar 

  110. Ritz, E., Krempien, B., Andrassy, K.: Niere und Knochensystem. Therapiewoche 28, 1973, 2402–2403

    Google Scholar 

  111. Ritz, E., Sieberth, H. G., Krempien, B.: Ca-Stoffwechselstörungen bei chronischer Niereninsuffizienz. Klin. Wschr. 49, 1971, 1305–1314

    PubMed  CAS  Google Scholar 

  112. Roth, S. I., Marshall, R. B.: Pathology and Ultrastructure of the Human Parathyroid Glands in Chronic Renal Failure. Arch. Intern. Med. 124, 1969, 397–407

    PubMed  CAS  Google Scholar 

  113. Russel, R. G.G. G., Smith, R., Walton, R. J., Preston, C., Basson, R., Henderson, R. G., Norman, A. W.: 1,25-Dihydroxycholecalciferol and 1 α′-Hydroxycholecalciferol in Hypoparathyroidism. Lancet II, 1974, 14–19

    Google Scholar 

  114. Schaefer, K., von Herrath, D., Kraft, D.: Vitamin D-Stoffwechsel und chronische Niereninsuffizienz. Dtsch. med. Wschr. 98, 1973, 1338–1344

    PubMed  CAS  Google Scholar 

  115. Schaefer, K., Opitz, A.: Aktuelle Probleme azotämischer Knochenerkrankungen. Dtsch. med. Wschr. 95, 1970, 84–88

    PubMed  CAS  Google Scholar 

  116. Schaefer, K., Opitz, A., Stratz, R., Koch, H.-U., von Herrath, D.: Der Stoffwechsel von 25-hydroxycholecalciferol bei Gesunden und nephrektomierten Patienten. Dtsch. med. Wschr. 96, 1971, 798–799

    PubMed  CAS  Google Scholar 

  117. Schaefer, K., Schaefer, P., Koeppe, P., Opitz, A., Höffler, D.: Untersuchungen zur Therapie der urämischen Osteopathie. Dtsch. med. Wschr. 94, 1969, 70–72

    PubMed  CAS  Google Scholar 

  118. Schulz, W., Delling, G., Schulz, A., Heidier, R., Gessler, U.: Vergleichende klinische und histomorphometrische Untersuchungen zum Ausmaß und zur Entwicklung der renalen Osteopathie. Nieren-und Hochdruckkrankheiten 1, 1974, 169–174

    Google Scholar 

  119. Schellhorn, W.: „Kalkgicht“ mit Nephrokalzinose, verursacht durch Langzeittherapie mit Dihydrotachysterin. Med. Klin. 1972, 1232–1237

    Google Scholar 

  120. Sherwood, L. M., Herrmann, I., Basset, C. A.: In Vitro Studies of Normal and Abnormal Parathyroid Tissue. Arch. Intern. Med. 124, 1969, 426–430

    PubMed  CAS  Google Scholar 

  121. Spannagel, B., Ritz, E.: Intestinaler Ca-Transport bei experimenteller Urämie. Verh. Ges. Nephrologie 1970

    Google Scholar 

  122. Stanbury, S. W.: The Treatment of Renal Osteodystrophy. Ann. Intern. Med. 65, 1966, 1133–1139

    PubMed  CAS  Google Scholar 

  123. Stanbury, S. W.: Metabolic Studies of Renal Osteodystrophy. Medicine (Baitimore) 1962, 41, 1–9

    CAS  Google Scholar 

  124. Stanbury, S. W., Lumb, G. A., Nicholson, W. F.: Elective subtotal parathyroidectomy for Renal Hyperparathyroidism. Lancet I, 1960, 793–798

    Google Scholar 

  125. Slatopolsky, E., Caglar, S., Pennell, J. P., Taggart, D. D., Canterbury, J. M., Reiss, E., Bricker, N. S.: On the Pathogenesis of Hyperparathyroidism in Chronic Experimental Renal Insufficiency in the Dog. J. Clin. Invest. 50, 1971, 492–499

    PubMed  CAS  Google Scholar 

  126. Suda, T., Hallick, R. B., DeLuca, H. F., Schnoes, H. K.: 25-Hydroxydihydro tachysterol. Synthesis and Biological Activity. Biochemistry 9, 1970, 1651–1657

    PubMed  CAS  Google Scholar 

  127. Tanaka, Y., Chen, T. C., DeLuca, H. F.: Dependence of 25-Hydroxycholecalciferol-Hydroxylase Regulation on RNA and Protein Synthesis. Arch. Biochem. Biophy. 152, 1972, 291–298

    CAS  Google Scholar 

  128. Tanaka, Y., DeLuca, H. F.: Bone Mineral Mobilization Activity of 1,25-Dihydroxycholecalciferol, a Metabolite of Vitamin D. Arch. Biochem. Biophy. 146, 1971, 574–578

    CAS  Google Scholar 

  129. Tanaka, Y., DeLuca, H. F., Omdahl, J., Holick, M. F.: Mechanism of Action of 1,25-Dihydroxycholecalciferol on Intestinal Calcium Transport. Proc. Nat. Acad. Sci. USA 68, 1971, 1286–1288

    PubMed  CAS  Google Scholar 

  130. Taylor, A. N., Wasserman, R. H.: Correlation between the Vitamin D-Induced Calcium Binding Protein and Intestinal Absorption of Calcium. Fed. Proc. 28, 1969, 1834–1938

    PubMed  CAS  Google Scholar 

  131. Terepka, A. R., Toribara, T. Y., Dewey, P. A.: The Ultrafiltrable Calcium of Human Serum. II. Variations in Disease States and under Experimental Conditions. J. Clin. Invest. 37, 1958, 87–98

    PubMed  CAS  Google Scholar 

  132. Trummel, C. L., Raisz, H. L., Blunt, J. W., DeLuca, H. F.: 25-Hydroxycholecalciferol: Stimulation of Bone Resorption in Tissue culture. Sci. 163, 1969, 1450–1455

    CAS  Google Scholar 

  133. Tschöpe, W., Ritz, E., Bommer, J., Krempien, B., Andrassy, K., Mehls, O.: Wirbelkörperkollaps bei Dialyse-Osteopathie. Dtsch. med. Wschr. 98, 1973 1471–1474

    PubMed  Google Scholar 

  134. Wasserman, R. H., Taylor, A. N.: Die physiologische Bedeutung des Vitamin D-abhängigen calciumbindenden Proteins. Triangel 12, 1974, 119–127

    Google Scholar 

  135. Wasserman, R. H., Taylor, A. N.: Evidence for a Vitamin D3-Induced Calcium-Binding Protein in New World Primates. Proc. Soc. Exp. Biology Med. 136, 1971, 25–28

    CAS  Google Scholar 

  136. Wong, R G., Norman, A. W., Reddy, Ch. R., Coburn, J. W.: Biologic Effects of 1,25-Dihydroxycholecalciferol (a Highly Active Vitamin D Metabolite) in Actuely Uremic Rats. J. Clin. Invest. 51, 1972, 1287–1291

    PubMed  CAS  Google Scholar 

  137. Ziegler, R., Minne, H., Bellwinkel, S., Fröhlich, D.: Hypercalciämie-Syndrom und hypercalciämische Krise. Dtsch. med. Wschr. 98, 1973, 276–283

    PubMed  CAS  Google Scholar 

  138. Ziegler, R., Minne, H., Raue, F., Paar, G., Delling, G.: Beobachtungen zur Vitamin-D-und Dihydrotachysterin-Vergiftung. Dtsch. med. Wschr. 100, 1975, 415–423

    PubMed  CAS  Google Scholar 

Section 7

  1. Adamson, J. W., Eschbach, J., Finch, C. H.: The kidney and erythropoiesis. Am. J. Med. 44, 725–733 (1968)

    PubMed  CAS  Google Scholar 

  2. Alexanian, R.: Erythropoietin and erythropoiesis in anemic man following androgens. Blood 33, 564–567 (1969)

    PubMed  CAS  Google Scholar 

  3. Augustin, H. J., Kapoun, W., Kötter, C.: Der Einfluß von Testosteron auf die Anämie bei terminaler Niereninsuffizienz. Dtsch. med. Wschr. 98, 2119–2122 (1973)

    PubMed  CAS  Google Scholar 

  4. Babb, A. L., Popovich, R. P., Christopher, G. L., Scribner, B. H.: The genesis of the square-meter-hour hypothesis. Trans. Amer. Soc. Artif. Intern. Organs 17, 81–89 (1971)

    CAS  Google Scholar 

  5. Becker, E.: Nierenkrankheiten. Bd. I. Jena: G. Fischer 1944

    Google Scholar 

  6. Blumberg, A.: Die renale Anämie. Bern-Stuttgart-Wien: Hans Huber 1972a

    Google Scholar 

  7. Blumberg, A.: Die Anämie bei chronischer Niereninsuffizienz. Schweiz. med. Wschr. 102, 1044–1049 (1972b)

    PubMed  CAS  Google Scholar 

  8. Blumberg, A., Chappius, L.: Die enterale Eisenresorption bei der chronischen Niereninsuffizienz unter Langzeit-Dialysebehandlung. Klin. Wschr. 49, 41–46 (1971)

    PubMed  CAS  Google Scholar 

  9. Bock, H. E.: Die Blutarmut der Nierenkranken. Med. Welt 1, 1–12 (1963)

    Google Scholar 

  10. Bock, H. E., Löhr, G. W., Waller, H. D.: Beitrag zur Pathogenese der renalen Anämie. Schweiz. med. Wschr. 91, 1213–1218 (1963)

    Google Scholar 

  11. Boddy, K., Lawson, D. H., Linton, A. L., Will, G.: Iron metabolism in patients with chronic renal failure. Clin. Sci. 39, 115–118 (1970)

    PubMed  CAS  Google Scholar 

  12. Bright, R.: Guy’s Hospital Report 1, 338 (1835)

    Google Scholar 

  13. Brown, R.: Plasma erythropoietin in chronic uremia. Brit. Med. J. 2, 1036–1039 (1965)

    PubMed  CAS  Google Scholar 

  14. Büchner, F.: Spezielle Pathologie Band II, p. 30. München: Urban & Schwarzenberg 1974

    Google Scholar 

  15. Carnot, M. P., Deflandre, C.: Sur l’activité hémopoiétique des différents organes au cours de la régénération du sang. C. R. Acad. Sci. Paris 143, 432–435 (1906)

    Google Scholar 

  16. Contrera, J. F., Gordon, A. S.: The renal erythropoietic factor. Studies on its purification and properties. Ann. N.Y. Acad. Sci. 149, 114–119 (1968)

    PubMed  CAS  Google Scholar 

  17. Contrera, J. F., Gordon, A. S., Weintraub, A. H.: Extraction of an erythropoietin produeing factir from a particulate fraction of rat kidney. Blood 28, 330–343 (1966)

    PubMed  CAS  Google Scholar 

  18. Denny, W. F., Flanigan, W. J., Zukowski, F.: Serial erythropoietin studies in patients undergoing renal homotransplantation. J. Lab. Clin. Med. 67, 386–389 (1964)

    Google Scholar 

  19. Desforges, J. F., Dawson, J. P.: The anemia of renal failure. Arch. Intern. Med. 101, 326–332 (1958)

    CAS  Google Scholar 

  20. Dombuk, D. H., Lindholm, D. D., Uishita, J. A.: Lipid metabolism in uremia and the effects of dialysate glucose and oral androgen therapy. Trans. Amer. Soc. Artif. Intern. Organs 19, 150–153 (1973)

    Google Scholar 

  21. van Dyke, D., Pollycove, M., Laurence, J. H.: Erythropoietin therapy in the renoprival patient. In: Semi-annual report. Biology and Medicine, Donner Laboratory and Donner Pavilion, Lawrence Radiation Laboratory, p. 127. 1967

    Google Scholar 

  22. Edwards, M. S., Pegrum, G. D., Curtis, J. R.: Iron therapy in patients on maintenance hemodialysis. Lancet II, 1970, 491–493

    Google Scholar 

  23. Erslev, A. J.: Humoral regulation of red cell production. Blood 8, 349–357 (1953)

    PubMed  CAS  Google Scholar 

  24. Erslev, A. J.: Erythropoietic function in uremic rabbits. Arch. Intern. Med. 101, 407–417 (1958)

    CAS  Google Scholar 

  25. Erslev, A. J.: Erythropoetic function of the kidney. In: Wessen, Physiology of the human kidney, pp 521–534 Grune & Stratton New York: 1969

    Google Scholar 

  26. Erslev, A. J.: Management of the anemia of chronic renal failure. Clin. Nephrology 2, 174–178 (1974)

    CAS  Google Scholar 

  27. Erslev, A. J., Kazal, L. A.: Renal erythropoietic factor. Lack of effect on hyper-transfused mice. Blood 34, 222–225 (1969)

    PubMed  CAS  Google Scholar 

  28. Eschbach, J. W., Adamson, J.. W.: Improvement in the anemia of chronic renal failure with fluoxymesterone. Arch. Intern. Med. 78, 527–534 (1973)

    CAS  Google Scholar 

  29. Eschbach, J. W., Cook, J. D., Finch, C. A.: Iron absorption in chronic renal disease. Clin. Sci. 38, 191–196 (1970)

    PubMed  CAS  Google Scholar 

  30. Eschbach, J. W., Finch, C. H.: Anemia and hemodialysis. Proc. Fifth Internat. Congr. Nephrol. Stockholm, 1968, p. 165–175

    Google Scholar 

  31. Eschbach, J. W., Funk, D., Adamson, J., Kuhn, J., Scribner, B. H., Finch, C. A.: Erythropoiesis in patients with renal failure undergoing chronic dialysis. New Engl. J. Med. 276, 653–658 (1967)

    PubMed  Google Scholar 

  32. Eschbach, J. W., Adamson, J. W., Cook, J. D.: Disorders of red blood cell production in uremia. Arch. Intern. Med. 126, 812–815 (1970)

    PubMed  CAS  Google Scholar 

  33. Espada, J., Langton, A. A., Dorado, M.: Human erythropoietin. Studies on purity and partial characterization. Biochem. Biophys. Acta 285, 427–433 (1972)

    PubMed  CAS  Google Scholar 

  34. Essers, U.: Habilitationsschrift Aachen 1972

    Google Scholar 

  35. Essers, U., Brass, A., Spicker, K.: Die aplastische Anämie bei Niereninsuffizienz — eine inhibitorische Wirkung des Urämieserums auf Erythropoietin ? Klin. Wschr. 48, 92–95 (1970)

    PubMed  CAS  Google Scholar 

  36. Fisher, J. W., Hatch, F. E., Roh, B. L., Alless, R. C., Kelley, B. J.: Erythropoietin inhibitor in kidney extracts and plasma from anemic uremic human subjects. Blood 31, 440–452 (1968)

    PubMed  CAS  Google Scholar 

  37. Fried, W., Jonasson, O., Lang, C., Schwartz, F.: The hematologic effect of androgen in uremic patients. Ann. Intern. Med. 79, 823–827 (1973)

    PubMed  CAS  Google Scholar 

  38. Fried, W., Kilbridge, T.: Effect of testosterone and of cobalt on erythropoietin production by anephric rats. J. Lab. Clin. Med. 74, 623–628 (1969)

    PubMed  CAS  Google Scholar 

  39. Fried, W., Kilbridge, T., Krantz, S., McDonald, T. P., Lange, R. D.: Studies on extrarenal erythropoietin. J. Lab. Clin. Med. 73, 244–248 (1969)

    PubMed  CAS  Google Scholar 

  40. Gallagher, N. J., McCarthy, J. M., Lange, R. D.: Erythropoietin production in uremic rabbits. J. Lab. Clin. Med. 57, 281–289 (1961)

    PubMed  CAS  Google Scholar 

  41. Giordano, C., DeSanto, N. G., Rinaldi, S., Acove, D., Esposito, E., Gallo, B.: Histidine supplements in the treatment if uremic anemia. Proc. 10th Congr. Europ. Dialysis and Transplanation Assoc. Vienna, 1973, p. 160

    Google Scholar 

  42. Giovanetti, S., Giagnoni, P., Balestri, P. L., et al.: Red cell survival inchronic uremia: Its relationship with the spontaneous in vitro autohemolysis and with the degree of anemia. Experientia 27, 739–741 (1966)

    Google Scholar 

  43. Gordon, A. S., Cooper, G. W., Zanjani, E. D.: The kidney and erythropoiesis. Sem. Haematol. 4, 337–358 (1969)

    Google Scholar 

  44. Gordon, A. S., Zanjani, E. D.: Biogenesis of erythropoietin. Proc. Symposion Erythropoieticum, Prague, 1970

    Google Scholar 

  45. de Gowin, R. L., Lavender, A. R., Forland, M., Charleston, D., Gottschalk, A.: Erythropoiesis and erythropoietin in patients with chronic renal failure treated with hemodialysis and testosterone. Ann. Int. Med. 72, 913–918 (1970)

    Google Scholar 

  46. Gray, S. J., Sterling, K.: The tagging of red cells and plasma proteins with radioactive chromium. J. Clin. Invest. 29, 1604–1907 (1950)

    PubMed  CAS  Google Scholar 

  47. Hampers, L., Streiff, R., Nathan, D. G., et al.: Megaloblastic hematopoiesis in uremia and in patients on longterm hemodialysis. New Engl. J. Med. 276, 551–554 (1967)

    PubMed  CAS  Google Scholar 

  48. Heilmann, E.: Das Verhalten des Erythropoietinspiegels im Serum bei verschiedenen Nierenerkrankungen. Verh. dtsch. Ges. inn. Med. 79, 451–453 (1973)

    PubMed  CAS  Google Scholar 

  49. Heilmann, E., Loew, H., Schullenbach, U.: Zur Frage der hämolytischen Komponente der Anämie bei Hämodialyse-Patienten. Kongreßbericht d. Ges. f. inn. Med., Hamburg, 1974a

    Google Scholar 

  50. Heilmann, E., Cicinnati, C., Müller, H.: Erythropoietin in polycythemic mice and dialysed patients treated with androgens. Kongreßber. Internat. NephrologenKongreß, Vittel, 1974b

    Google Scholar 

  51. Heilmann, E.: Beziehungen zwischen Eisenbindungskapazität und den Eisenreserven im Knochenmark bei Dauerdialyse-Patienten. Ninth Symposion Ges. f. Nephrologie, Basel, 1973

    Google Scholar 

  52. Heilmann, E., Michael, C., Loew, H., Müller, H.: Untersuchungen zur Diagnose und Therapie des Eisenmangels bei Dauerdialyse-Patienten. Verh. dtsch. Ges. inn. Med. 80, 679–681 1974c)

    PubMed  CAS  Google Scholar 

  53. Hoffmann, G, G.: Human erythropoiesis following kidney transplantation. Ann. N.Y. Acad. Sci. 149, 504–506 (1968)

    Google Scholar 

  54. Hughes-Jones, N. C., Mollison, P. C.: The interpretation of measurements with 51Cr-labelled red cells. Clin. Sci. 15, 207–212 (1956)

    Google Scholar 

  55. Hurst, G. A., Chanutin, A.: Orgariic phosphate compounds of erythrocytes from individuals with uremia. J. Lab. Clin. Med. 64, 675–678 (1964)

    Google Scholar 

  56. Hyde, S. E., Sattler, J. H.: Red blood cell destruction in hemodialysis. Trans. Am. Soc. Artif. Int. Organs 15, 50–52 (1969)

    Google Scholar 

  57. Jacobson, L. O., Goldwasser, E., Fried, W., Plzak, L. F.: Studies on erythropoiesis VII: The role of the kidney in the production of erythropoietin. Trans. A. Am. Physicians 70, 633–634 (1957)

    Google Scholar 

  58. Johnson, F. L., Fengler, J. R., Lerner, K. G., Majerus, P. W., Siegel, M., Hartmann, J. R., Thomas, E. D.: Association of androgenic-anabolic steroid therapy with development of hepato-cellular carcinoma. Lancet 11, 1273–1278 (1972)

    Google Scholar 

  59. Joist, J. H., Heller, A., Küttringhaus, U., et al.: Zur Frage der Entwicklung und Bedeutung eines Folsäuremangels bei fortgeschrittener chronischer Niereninsuffizienz. Klin. Wschr. 47, 861–864 (1969)

    PubMed  CAS  Google Scholar 

  60. Joske, R. A., McAlister, J. M., Polenkerd, T. A. J.: Isotope investigations of red cell production and destruction in chronic renal disease. Clin. Sci. 15, 511–522 (1956)

    PubMed  CAS  Google Scholar 

  61. Kasanen, A., Kallimaki, J. L.: Correlation of some kidney function tests with hemoglobin in chronic nephropathies. Acta med. Scand. 158, 213–215 (1957)

    PubMed  CAS  Google Scholar 

  62. Kaye, M.: The anemia assaciated with renal disease. J. Lab. Clin. Med. 52, 83–100 (1958)

    PubMed  CAS  Google Scholar 

  63. Keller, H. M.: Veränderungen der Erythrocyten und der roten Blutbildung bei Nierenkrankheiten. Handb. d. Inn. Medizin, 5. Aufl., Bd. VIII/2, p. 169 (1968)

    Google Scholar 

  64. Koch, K. M., Patyna, W. D., Shalden, S., Werner, E.: Anemia of the regular hemodialysis patient and its treatment. Nephron 12, 405–419 (1974)

    PubMed  CAS  Google Scholar 

  65. Koch, K. M., Werner, E., Patyna, W. D., Kaltwasser, P.: Die intestinale Eisenadsorption bei fortgeschrittener Niereninsuffizienz. Der Einfluß der HämodialyseBehandlung. (In press)

    Google Scholar 

  66. Kraft, D., Freund, D., Karow, J.: Die Wirkung von Mesterolon auf die Erythropoese chronisch hämodialysierter Patienten. Dtsch. med. Wschr. 99, 1119–1125 (1974)

    PubMed  CAS  Google Scholar 

  67. Kuroyanagi T.: Anemia associated with chronic renal failure with special reference to kinetics of erythron. Acta haematol. Jap. 24, 48–67 (1961)

    Google Scholar 

  68. Lasker, N., Harvey, A., Baker, H.: Vitamin levels in hemodialysis and intermittent peritoneal dialysis. Trans. Amer. Soc. Artif. Intern. Organs 9, 51–55 (1963)

    Google Scholar 

  69. Lindholm, D. D., Fisher, J. W., Vihira, J. A., Dombeck, D. H., Bonal, G., Lerthora, J.: Clinical effect of oral fluoxymesterone in patients with dialysis-controlled uremia. Trans. Amer. Soc. Artif. Intern. Organs 19, 475–483 (1973)

    CAS  Google Scholar 

  70. Mackenzie, J. C., Ford, J. E., Waters, A. H., et al.: Erythropoiesis in patients undergoing regular dialysis treatment without transfusion. Proc. Europ. Dial. Transl. Ass. 5, 172–175 (1968)

    Google Scholar 

  71. Maggiore, Q., Navalesi, R., Biagini, M., Balestri, P. L., Giagnoni, P.: Comparative studies on uremic anemia in polycystic kidney disease and in other renal diseases. Proc. Europ. Dial. Transpl. Ass. 5, 264–266 (1967)

    Google Scholar 

  72. Mertz, D. P., Koschnik, R.: Nephrogene Anämie und Nierenhämodynamik. Schweiz. med. Wschr. 95, 83–88 (1965)

    PubMed  CAS  Google Scholar 

  73. Mirand, E. A.: Extrarenal and renal control of erythropoietin production. Ann. N.Y. Acad. Sci. 149, 94–96 (1968)

    PubMed  CAS  Google Scholar 

  74. Mirand, A. E., Murphy, G. P., Steeves, R. A., et al: Erythropoietin activity in anephric, allotransplanted, unilaterally nephrectomiced, and intact man. J. Lab. Clin. Med. 73, 121–128 (1969)

    PubMed  CAS  Google Scholar 

  75. Mirand, E. A., Murphy, G. P., Steeves, R. A., Weber, H. W., Retief, F. P.: Extrarenal production of erythopoietin in man. Acta haemotol. 39, 359–365 (1963)

    Google Scholar 

  76. Mirand, E. A., Prentice, T. C.: Presence of plasma erythropoietin in hypoxie rats with or without kidneys or spleen. Proc. Soc. Exper. Biol. Med. 96, 49–51 (1957)

    CAS  Google Scholar 

  77. Morgan, J. M., Morgan, R. E.: Study of the effect of uremic metabolit es on erythrocyte glycolysis. Metabolism 13, 629–632 (1964)

    PubMed  CAS  Google Scholar 

  78. Murphy, G. P., Mirand, E. A., Kenny, G. M.: Renal and extrarenal erythropoietin in man. N. Y. State J. Med. 69, 2007–2011 (1969)

    PubMed  CAS  Google Scholar 

  79. Murphy, G. P., Mirand, E. A., Grace, J. T.: Erythropoietin activity in anephric ar renal allotransplanted man. Am. Surg. 170, 581–583 (1969b)

    CAS  Google Scholar 

  80. Naets, J. P.: The role of the kidney in erythropoiesids. J. din. Invest. 39, 102–110 (1960)

    CAS  Google Scholar 

  81. Nathan, D. G., Beck, L. H., Hampers, C. G.: Erythrocyte production and metabolism in anephric and uremic man. Ann. N.Y. Acad. Sci. 149, 539–543 (1968)

    PubMed  CAS  Google Scholar 

  82. Neff, S. M., Kim, K. E., Persoff, M., Onesti, G., Swartz, C.: Hemodynamics of uremic anemia. Circulation 43, 866–883 (1971)

    Google Scholar 

  83. Polesky, H. F., McCullough, J., Helgeson, M. A., Nelson, C.: Evaluation of methods for preparation of HLA-antigen poor blood. Transfusion 13, 383–38 5(1973)

    PubMed  CAS  Google Scholar 

  84. Prankerd, R. A. J.: The role of red cell enzymes in hemolysis. Brit. J. Haematol. 7, 405–407 (1961)

    Google Scholar 

  85. Reissmann, C. R.: Studies on the mechanism of erythropoietic stimulation in parabiotic rats during hypoxia. Blood 5, 372–380 (1950)

    PubMed  CAS  Google Scholar 

  86. Reissmann, K. R., Nomura, T., Gunn, W. R., et al.: Erythropoietic response to anemia or erythropoietin injections in uremic rats. Blood 16, 1411–1423 (1960)

    PubMed  CAS  Google Scholar 

  87. Renner, H. D.: Zellstoffwechselstörungen bei Urämie. Habilitationsschrift, Aachen, 1968

    Google Scholar 

  88. Richardson, J. R., jr., Weinstein, M. B.: Erythropoietie response of dialysed patients to testosterone administration. Ann. Intern. Med. 73, 403–407 (1970)

    PubMed  Google Scholar 

  89. Sass, M. D., Vorsanger, E., Spear, P. W.: Enzyme activity as an indicator of red cell age. Clin. Chim. Acta (Amsterd.) 10, 21–23 (1964)

    CAS  Google Scholar 

  90. Scribner, B. H., Burri, R., Cones, J.E. Z., et al.: The treatment of chronie uremia by means of intermittent hemodialysis: a preliminary report. Trans. Amer. Soc. Artif. Intern. Organs 6, 114–119 (1960)

    CAS  Google Scholar 

  91. Shahidi, N. T.: Androgens and erythropoiesis. New Engl. J. Med. 289, 72–80 (1973)

    PubMed  CAS  Google Scholar 

  92. Shaldon, S., Koch, K. M., Oppermann, F., Patyna, W. D., Schoeppe, W.: Testosterone therapy for anemia: 25 patients in maintenance dialysis. Brit. Med. J. 3, 212–215 (1971a)

    PubMed  CAS  Google Scholar 

  93. Shaldon, S., Patyna, W. D., Kaltwasser, P., Werner, E., Koch, K. M., Schoeppe, W. E.: The use of testosterone in bilateral nephrectomized dialysis patients. Trans. Amer. Soc. Artif. Intern. Organs 17, 104–107 (1971b)

    CAS  Google Scholar 

  94. Shaw, A. B.: Hemolysis in chronic renal failure. Brit. Med. J. 11, 213–216 (1967)

    Google Scholar 

  95. Sill, V., Lanser, K. G., Bauditz, W.: Einfluß der Anämie auf die körperliche Leistungsfähigkeit von Dauerdialyse-Patienten. Z. Kardiol. 62, 164–175 (1973)

    PubMed  CAS  Google Scholar 

  96. Stewart, J. H.: Hemolytie anemia in acute and chronicrenalfailure. Quart. J. Med. 36, 85–105 (1967)

    Google Scholar 

  97. Volhard, F.: Die doppelseitigen hämatogenen Nierenerkrankungen. In: Handbuch d. Inn. Medizin, 2. Aufl. Berlin: Springer 1931

    Google Scholar 

  98. Werner, E., Fink-Rosskamp, P., Oppermann, F., Patyna, W. D., Koch, K. M., Schoeppe, W.: Die Bestimmung des individuellen Gesamtblutverlustes bei der chronischen Hämodialyseals Grundlage für die optimale Eisensubstitution. Tenth Intern. Jahrestagg d. Ges. Nuklearmedizin, Freiburg, 1972

    Google Scholar 

  99. Whitehead, V. M., Compty, C. H., Poser, G. A., et al.: Homeostasis of folie acid in patients undergoing maintenance hemodialysis. New Engl. J. Med. 279, 970–974 (1968)

    PubMed  CAS  Google Scholar 

  100. Ypersele de Stritou, C. van, Vandenbroucke, J. N., Stragier, A.: Anemia in maintenance hemodialysis. Klin. Nephrologie 1, 2/I, p. 26–33 (1972)

    Google Scholar 

  101. Zanjani, E. D., Contrera, J. F., Gordon, A. S., Cooper, G. W., Wong, K. K., Katz, R.: The renal erythropoietic factor (REF) IH. Enzymatic role in erythropoietin production. Proc. Soc. Exper. Biol. New York 125, 505–508 (1967)

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Universitäts-Poliklinik Münster, Germany

    H. Loew, A. Samizadeh & E. Heilmann

Authors
  1. H. Loew
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Samizadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Heilmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pathologisches Institut der Universität, Westring 17, D-4400, Münster/Westf., Germany

    E. Grundmann (Professor Dr.) (Professor Dr.)

Rights and permissions

Reprints and permissions

Copyright information

© 1976 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Loew, H., Samizadeh, A., Heilmann, E. (1976). New Clinical Syndromes under Regular Intermittent Hemodialysis. In: Grundmann, E. (eds) Glomerulonephritis. Current Topics in Pathology, vol 61. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66221-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-66221-8_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-66223-2

  • Online ISBN: 978-3-642-66221-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation